MOTS-c and SS-31 are both used in mitochondrial research but differ in kind: MOTS-c is a 16-residue peptide encoded in the mitochondrial genome and studied for folate-cycle and AMPK signaling, while SS-31 is a synthetic four-residue peptide studied for its association with the inner mitochondrial membrane. This comparison covers structure, reported mechanism and assay design for MOTS-c and SS-31 as laboratory materials.
How do MOTS-c and SS-31 compare side by side?
| Property | MOTS-c | SS-31 (elamipretide) |
|---|---|---|
| Origin | Encoded by the mitochondrial 12S rRNA gene | Synthetic, designed aromatic-cationic tetrapeptide |
| Length | 16 amino acids | 4 amino acids |
| Sequence | MRWQEMGYIFYPRKLR | D-Arg-Dmt-Lys-Phe-NH2 |
| Molecular formula | C101H152N28O22S2 | C32H49N9O5 |
| Molecular weight | 2174.6 g/mol | 639.8 g/mol |
| CAS number | 1627580-64-6 | 736992-21-5 |
| Reported site of activity | Cell signaling (folate cycle, AMPK; reported nuclear translocation under stress) | Inner mitochondrial membrane, associated with cardiolipin |
| Typical in vitro readouts | Phospho-AMPK, AICAR, ATP and AMP ratios, respiration | Membrane potential, mitochondrial reactive oxygen species, cardiolipin status, respiration |
| Vial sizes listed | 10 mg and 40 mg | 10 mg and 50 mg |
How do their structures differ?
SS-31 is a short, positively charged tetrapeptide built on an alternating aromatic and cationic residue pattern, including D-arginine and dimethyltyrosine. MOTS-c is a longer peptide with a natural sequence, two methionines and several basic residues. The size difference matters in practice: at 639.8 g/mol, 1 mg/mL of SS-31 is about 1.56 mM, versus about 0.46 mM for MOTS-c, so equal mass concentrations are very different molar concentrations. Use molarity when comparing the two.
How do their reported mechanisms differ?
MOTS-c has been reported to act on cellular metabolic signaling, through the folate cycle, AICAR and AMPK; the readouts are described in AMPK and folate-cycle assays for MOTS-c in vitro. SS-31 is reported to associate with cardiolipin on the inner mitochondrial membrane, which is the focus of SS-31 and the inner mitochondrial membrane. These are literature descriptions, not outcome claims, and each should be tested in your own cell system.
How would you design an experiment that uses both?
- Parallel arms: run each peptide in its own arm, matched on molar concentration, vehicle and incubation time.
- Shared readouts: respiration by extracellular flux and ATP levels allow direct comparison across both arms.
- Distinct readouts: keep phospho-AMPK and AICAR for MOTS-c, and membrane potential and mitochondrial reactive oxygen species probes for SS-31.
- Controls: a scrambled MOTS-c-length peptide and a matched-charge tetrapeptide control keep the two arms interpretable.
Verify the identity of each material before comparing them; see the COA guides for MOTS-c and SS-31.
Related research guides
- MOTS-c quick-reference profile: sequence, origin and assays
- A researcher's guide to SS-31 (elamipretide)
- Mitochondria-targeting research compounds: an in-vitro overview
- Measuring mitochondrial function in vitro: key assays
Research-use note
All materials discussed are supplied for in vitro laboratory research use only, and are not for human or animal use.








